Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE FMD VACCINE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 ECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 EPIDEMIOLOGY OF FOOT-AND-MOUTH DISEASE (FMD)
4.3.1 FMD INCIDENCE RATE BY SPECIES AND REGION
4.3.1.1 INCIDENCE BY SPECIES AND MORBIDITY BURDEN
4.3.1.2 PREVALENCE PATTERNS AND REGIONAL SEROTYPE DISTRIBUTION
4.3.2 VACCINATION COVERAGE RATE
4.4 MORTALITY AND MORBIDITY IMPACT
4.4.1 VACCINE COMPLIANCE AND PROGRAM ADHERENCE
4.4.2 DISEASE CONTAINMENT SUCCESS RATES
4.5 INDUSTRY INSIGHTS
4.5.1 MICRO AND MACRO ECONOMIC FACTORS
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.5.3 KEY PRICING STRATEGIES
4.5.4 INTERVIEWS WITH SPECIALISTS
4.5.5 ANALYSIS AND RECOMMENDATION
4.6 COMPANY EVALUATION QUADRANT
4.7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE EUROPE FMD VACCINE MARKET
4.8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE EUROPE FMD VACCINE MARKET
4.9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE EUROPE FMD VACCINE MARKET
4.1 EUROPE CLINICAL TRIAL MARKET FOR EUROPE FMD VACCINE MARKET
4.11 HEALTHCARE TARIFFS IMPACT ANALYSIS
4.11.1 OVERVIEW
4.11.2 TARIFF STRUCTURES
4.11.2.1 EUROPE VS. REGIONAL TARIFF STRUCTURES
4.11.2.2 UNITED STATES: USDA/APHIS TARIFF POLICIES, ANIMAL HEALTH PROGRAM MODELS
4.11.2.2.1 EUROPEAN UNION: CROSS-BORDER TRADE REGULATIONS, SUBSIDY POLICIES
4.11.2.2.2 ASIA-PACIFIC: IMPORT AND EXPORT CONTROLS ON VETERINARY VACCINES
4.11.2.2.3 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
4.11.3 PHARMACEUTICAL (VETERINARY BIOLOGICS) TARIFFS AND TRADE BARRIERS
4.11.3.1 IMPORT DUTIES ON VACCINES AND BIOLOGICALS
4.11.3.2 IMPACT ON AFFORDABILITY AND ACCESS IN RURAL AREAS
4.11.3.3 KEY TRADE AGREEMENTS AFFECTING ANIMAL HEALTH PRODUCT TARIFFS
4.11.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND FARMERS
4.11.4.1 COST BURDEN ON COMMERCIAL FARMS AND VETERINARIANS
4.11.4.2 EFFECT ON VACCINE AFFORDABILITY AND HERD COVERAGE
4.11.4.3 TARIFFS AND IMPACT ON ANIMAL TRADE/MOVEMENT
4.11.5 TRADE AGREEMENTS AND ANIMAL HEALTH TARIFFS
4.11.5.1 WTO REGULATIONS ON VETERINARY PRODUCTS
4.11.5.2 IMPACT OF TRADE WARS ON VACCINE SUPPLY CHAIN
4.11.5.3 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN TARIFF REDUCTION
4.11.6 IMPACT OF TARIFFS ON VETERINARY VACCINE COSTS & ACCESSIBILITY
4.11.7 IMPORTANCE OF TARIFFS IN THE ANIMAL HEALTH SECTOR
4.12 MARKETED VACCINE ANALYSIS
4.12.1 VACCINE BRAND & GENERIC NAME / ANTIGENIC STRAIN
4.12.2 INDICATION
4.12.3 PHARMACOLOGICAL CLASS OF THE VACCINE
4.12.4 PRIMARY INDICATION
4.12.5 MARKET STATUS
4.12.6 VACCINE TYPE (CONVENTIONAL, NEXT-GEN, ETC.)
4.12.7 DOSAGE FORM
4.12.8 DOSAGE AVAILABILITY
4.12.9 PACKAGING TYPE
4.12.10 ROUTE OF ADMINISTRATION
4.12.11 DOSING FREQUENCY
4.12.12 VACCINE INSIGHT
4.12.13 OVERVIEW OF DEVELOPMENT ACTIVITIES (APPROVALS, SAFETY, EFFICACY, MARKET EXCLUSIVITY)
4.12.13.1 FORECAST MARKET OUTLOOK
4.12.14 CROSS COMPETITION (BY STRAIN/VALENCY)
4.12.15 THERAPEUTIC PORTFOLIO
4.12.16 CURRENT DEVELOPMENT SCENARIO
4.13 PATENT ANALYSIS
4.13.1 PATENT QUALITY AND STRENGTH
4.13.2 COUNTRY PATENT LANDSCAPE
4.13.3 IP STRATEGY AND MANAGEMENT
4.13.4 LICENSING AND COLLABORATION
4.14 TOP ENTITIES BASED ON R&D GLANCE FOR EUROPE FMD VACCINE MARKET
4.15 MARKET ACCESS
4.15.1 10-YEAR MARKET FORECAST
4.15.2 CLINICAL TRIAL RECENT UPDATES
4.15.3 ANNUAL NEW VACCINE APPROVALS (OIE/REGIONAL AUTHORITIES)
4.15.4 LEADING MANUFACTURERS AND STRATEGIC DEALS
4.15.5 MAJOR VACCINE UPTAKE
4.15.6 CURRENT VACCINATION PRACTICES
4.15.7 IMPACT OF UPCOMING TECHNOLOGIES AND THERAPY
4.16 R & D ANALYSIS
4.16.1 COMPARATIVE ANALYSIS
4.16.2 VACCINE DEVELOPMENT LANDSCAPE
4.16.3 IN-DEPTH INSIGHTS ON REGULATORY MILESTONES
4.16.4 THERAPEUTIC ASSESSMENT
4.16.5 ASSET-BASED COLLABORATIONS AND PARTNERSHIPS
5 WAR-DRIVEN DISRUPTION IN VETERINARY VACCINE SUPPLY CHAINS, GEOGRAPHIC FOOTPRINTS, STRUCTURAL CHANGES, AND ADAPTIVE STRATEGIES
5.1 SUPPLY CHAIN RESILIENCE
5.1.1 DIVERSIFICATION OF ANTIGEN AND ADJUVANT INGREDIENT SUPPLIERS
5.1.2 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE MANUFACTURING HUBS
5.1.3 STRATEGIC STOCKPILING OF EMERGENCY VACCINE BANKS
5.1.4 DEVELOPMENT OF ALTERNATIVE COLD CHAIN LOGISTICS ROUTES
5.1.5 STRATEGIC PARTNERSHIPS WITH CONTRACT MANUFACTURERS (CDMOS)
5.1.6 EXPANSION OF VACCINE FILL-FINISH AND PACKAGING CAPACITIES
5.2 ENERGY & MANUFACTURING OPERATIONAL COST RISK
5.2.1 RISING ENERGY COSTS IN ANIMAL HEALTH PRODUCTION FACILITIES
5.2.2 INCREASED COSTS FOR BIOLOGICS RAW MATERIALS AND COMPONENTS
5.2.3 LONG-TERM ENERGY PROCUREMENT STRATEGIES FOR VETERINARY PLANTS
5.2.4 ADOPTION OF ENERGY-EFFICIENT BIOPHARMA MANUFACTURING TECHNOLOGIES
5.2.5 DEPLOYMENT OF ADVANCED AUTOMATION AND CONTINUOUS MANUFACTURING
5.2.6 INTEGRATION OF RENEWABLE ENERGY IN VETERINARY VACCINE PLANTS
5.3 GEOGRAPHIC FOOTPRINT REASSESSMENT
5.3.1 EXPANSION OF VACCINE PRODUCTION IN POLITICALLY STABLE REGIONS
5.3.2 DIVERSIFICATION OF EUROPE VETERINARY VACCINE BASES
5.3.3 RELOCATION OF ANTIGEN PRODUCTION FACILITIES
5.3.4 EXPANSION OF MANUFACTURING IN EMERGING ANIMAL HEALTH MARKETS
5.3.5 ESTABLISHMENT OF REGIONAL VETERINARY VACCINE DISTRIBUTION HUBS
5.4 SCENARIO PLANNING & RISK MANAGEMENT
5.4.1 DEVELOPMENT OF SUPPLY CHAIN CONTINGENCY PLANS FOR OUTBREAKS
5.4.2 MULTI-SOURCE PROCUREMENT STRATEGIES FOR KEY VACCINE INGREDIENTS
5.4.3 GOVERNMENT AND ANIMAL HEALTH AUTHORITY COLLABORATIONS
5.4.4 CRISIS-RESPONSE VACCINE DEPLOYMENT NETWORKS
5.4.5 DEPLOYMENT OF SUPPLY CHAIN ANALYTICS IN VACCINE DISTRIBUTION
5.5 CASH & FINANCIAL PROTECTION
5.5.1 STRENGTHENING CAPITAL RESERVES FOR MANUFACTURING EXPANSION
5.5.2 DIVERSIFICATION OF PRODUCT PORTFOLIOS AND REVENUE STREAMS
5.5.3 INVESTMENTS IN DOMESTIC VACCINE MANUFACTURING INFRASTRUCTURE
5.5.4 GOVERNMENT INCENTIVES FOR ANIMAL HEALTH PRODUCTION
5.5.5 LONG-TERM PROCUREMENT AGREEMENTS WITH GOVERNMENTS AND ORGANIZATIONS
5.6 DATA PROTECTION
5.6.1 DATA PROTECTION FRAMEWORKS FOR ANIMAL HEALTH R&D AND MANUFACTURING
5.6.2 PROTECTION OF VETERINARY CLINICAL TRIAL AND FIELD DATA
5.6.3 SECURE CLOUD INFRASTRUCTURE FOR VACCINE DATA MANAGEMENT
5.6.4 AI-DRIVEN THREAT DETECTION IN RESEARCH AND SUPPLY NETWORKS
5.6.5 COMPLIANCE WITH EUROPE ANIMAL HEALTH DATA REGULATIONS AND GXP STANDARDS
6 REGULATORY FRAMEWORK FOR FMD VACCINES
6.1 REGULATORY APPROVAL PROCESS FOR FMD VACCINES
6.1.1 INTERNATIONAL NORMS AND STANDARDS FOR FMD VACCINES
6.1.2 BIOSAFETY AND CONTAINMENT REGULATIONS
6.2 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.3 REGULATORY APPROVAL PATHWAYS FOR VETERINARY VACCINES
6.4 LICENSING AND REGISTRATION REQUIREMENTS
6.5 POST-MARKETING SURVEILLANCE FOR VETERINARY PRODUCTS
6.6 GOOD MANUFACTURING PRACTICES (GMP) GUIDELINES FOR ANIMAL HEALTH
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWTH IN EUROPE LIVESTOCK POPULATION
7.1.2 RISING PREVALENCE OF FMD OUTBREAKS
7.1.3 GROWING GOVERNMENT VACCINATION PROGRAMS
7.1.4 INCREASING AWARENESS OF ANIMAL HEALTH AND BIOSECURITY
7.2 RESTRAINTS
7.2.1 LIMITED COLD CHAIN INFRASTRUCTURE
7.2.2 VACCINE HESITANCY AND FIELD CHALLENGES
7.3 OPPORTUNITIES
7.3.1 INTEGRATION OF DIGITAL VETERINARY SURVEILLANCE SYSTEMS
7.3.2 RISING ADOPTION OF MULTIVALENT AND HIGH-POTENCY VACCINES
7.3.3 EMERGING MARKETS WITH HIGH LIVESTOCK POPULATIONS
7.4 CHALLENGES
7.4.1 VIRAL MUTATION AND SEROTYPE VARIABILITY
7.4.2 ENFORCEMENT OF VACCINATION REGULATIONS
8 EUROPE FMD VACCINE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 CONVENTIONAL VACCINES
8.3 NEXT-GENERATION / ADVANCED VACCINES
8.4 OTHERS
8.5 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
8.5.1 CONVENTIONAL VACCINES
8.5.2 NEXT-GENERATION / ADVANCED VACCINES
8.5.3 OTHERS
9 EUROPE FMD VACCINE MARKET, BY TYPE
9.1 OVERVIEW
9.2 INACTIVATED (KILLED) VACCINES
9.3 LIVE ATTENUATED VACCINES
9.4 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 ASIA-PACIFIC
9.4.2 EUROPE
9.4.3 NORTH AMERICA
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST AND AFRICA
9.5 EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.5.1 RECOMBINANT VECTOR-BASED VACCINES
9.5.2 VIRUS-LIKE PARTICLE (VLP) VACCINES
9.5.3 SUBUNIT VACCINES
9.5.4 OTHERS
9.6 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 ASIA-PACIFIC
9.6.2 EUROPE
9.6.3 NORTH AMERICA
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST AND AFRICA
9.7 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 ASIA-PACIFIC
9.7.2 EUROPE
9.7.3 NORTH AMERICA
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST AND AFRICA
9.8 EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.8.1 MULTIVALENT VACCINES
9.8.2 MONOVALENT VACCINES
9.9 EUROPE MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.9.1 ASIA-PACIFIC
9.9.2 EUROPE
9.9.3 NORTH AMERICA
9.9.4 SOUTH AMERICA
9.9.5 MIDDLE EAST AND AFRICA
9.1 EUROPE MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.10.1 ASIA-PACIFIC
9.10.2 EUROPE
9.10.3 NORTH AMERICA
9.10.4 SOUTH AMERICA
9.10.5 MIDDLE EAST AND AFRICA
10 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE
10.1 OVERVIEW
10.2 INTRAMUSCULAR
10.3 SUBCUTANEOUS
10.4 OTHERS
10.5 EUROPE INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.5.1 ASIA-PACIFIC
10.5.2 EUROPE
10.5.3 NORTH AMERICA
10.5.4 SOUTH AMERICA
10.5.5 MIDDLE EAST AND AFRICA
10.6 EUROPE SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.6.1 ASIA-PACIFIC
10.6.2 EUROPE
10.6.3 NORTH AMERICA
10.6.4 SOUTH AMERICA
10.6.5 MIDDLE EAST AND AFRICA
10.7 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.7.1 ASIA-PACIFIC
10.7.2 EUROPE
10.7.3 NORTH AMERICA
10.7.4 SOUTH AMERICA
10.7.5 MIDDLE EAST AND AFRICA
11 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE
11.1 OVERVIEW
11.2 BOVINE
11.3 PORCINE
11.4 OVINE
11.5 CAPRINE
11.6 OTHERS
11.7 EUROPE BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.7.1 ASIA-PACIFIC
11.7.2 EUROPE
11.7.3 NORTH AMERICA
11.7.4 SOUTH AMERICA
11.7.5 MIDDLE EAST AND AFRICA
11.8 EUROPE PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.8.1 ASIA-PACIFIC
11.8.2 EUROPE
11.8.3 NORTH AMERICA
11.8.4 SOUTH AMERICA
11.8.5 MIDDLE EAST AND AFRICA
11.9 EUROPE OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.9.1 ASIA-PACIFIC
11.9.2 EUROPE
11.9.3 NORTH AMERICA
11.9.4 SOUTH AMERICA
11.9.5 MIDDLE EAST AND AFRICA
11.1 EUROPE CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.10.1 ASIA-PACIFIC
11.10.2 EUROPE
11.10.3 NORTH AMERICA
11.10.4 SOUTH AMERICA
11.10.5 MIDDLE EAST AND AFRICA
11.11 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.11.1 ASIA-PACIFIC
11.11.2 EUROPE
11.11.3 NORTH AMERICA
11.11.4 SOUTH AMERICA
11.11.5 MIDDLE EAST AND AFRICA
12 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE
12.1 OVERVIEW
12.2 LIQUID VACCINES
12.3 LYOPHILIZED (FREEZE-DRIED) VACCINES
12.4 OTHERS
12.5 EUROPE LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 ASIA-PACIFIC
12.5.2 EUROPE
12.5.3 NORTH AMERICA
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST AND AFRICA
12.6 EUROPE LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 ASIA-PACIFIC
12.6.2 EUROPE
12.6.3 NORTH AMERICA
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST AND AFRICA
12.7 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.7.1 ASIA-PACIFIC
12.7.2 EUROPE
12.7.3 NORTH AMERICA
12.7.4 SOUTH AMERICA
12.7.5 MIDDLE EAST AND AFRICA
13 EUROPE FMD VACCINE MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ROUTINE PROPHYLACTIC VACCINATION
13.3 EMERGENCY VACCINATION (OUTBREAK CONTROL)
13.4 OTHERS
13.5 EUROPE ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 ASIA-PACIFIC
13.5.2 EUROPE
13.5.3 NORTH AMERICA
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST AND AFRICA
13.6 EUROPE EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 ASIA-PACIFIC
13.6.2 EUROPE
13.6.3 NORTH AMERICA
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST AND AFRICA
13.7 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.7.1 ASIA-PACIFIC
13.7.2 EUROPE
13.7.3 NORTH AMERICA
13.7.4 SOUTH AMERICA
13.7.5 MIDDLE EAST AND AFRICA
14 EUROPE FMD VACCINE MARKET, BY END USER
14.1 OVERVIEW
14.2 COMMERCIAL LIVESTOCK FARMS
14.3 VETERINARY HOSPITALS
14.4 VETERINARY CARE CENTERS
14.5 VACCINATION CENTRES
14.6 OTHERS
14.7 EUROPE COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 ASIA-PACIFIC
14.7.2 EUROPE
14.7.3 NORTH AMERICA
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST AND AFRICA
14.8 EUROPE VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 ASIA-PACIFIC
14.8.2 EUROPE
14.8.3 NORTH AMERICA
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST AND AFRICA
14.9 EUROPE VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.9.1 ASIA-PACIFIC
14.9.2 EUROPE
14.9.3 NORTH AMERICA
14.9.4 SOUTH AMERICA
14.9.5 MIDDLE EAST AND AFRICA
14.1 EUROPE VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.10.1 ASIA-PACIFIC
14.10.2 EUROPE
14.10.3 NORTH AMERICA
14.10.4 SOUTH AMERICA
14.10.5 MIDDLE EAST AND AFRICA
14.11 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.11.1 ASIA-PACIFIC
14.11.2 EUROPE
14.11.3 NORTH AMERICA
14.11.4 SOUTH AMERICA
14.11.5 MIDDLE EAST AND AFRICA
15 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY)
15.3 RETAIL SALES
15.4 OTHERS
15.5 EUROPE DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.5.1 ASIA-PACIFIC
15.5.2 EUROPE
15.5.3 NORTH AMERICA
15.5.4 SOUTH AMERICA
15.5.5 MIDDLE EAST AND AFRICA
15.6 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
15.6.1 HOSPITAL PHARMACY
15.6.2 RETAIL PHARMACY
15.6.3 ONLINE PHARMACY
15.7 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.7.1 ASIA-PACIFIC
15.7.2 EUROPE
15.7.3 NORTH AMERICA
15.7.4 SOUTH AMERICA
15.7.5 MIDDLE EAST AND AFRICA
15.8 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.8.1 ASIA-PACIFIC
15.8.2 EUROPE
15.8.3 NORTH AMERICA
15.8.4 SOUTH AMERICA
15.8.5 MIDDLE EAST AND AFRICA
16 EUROPE FMD VACCINE MARKET, BY REGION
16.1 EUROPE
16.1.1 TURKEY
16.1.2 RUSSIA
16.1.3 GERMANY
16.1.4 FRANCE
16.1.5 U.K.
16.1.6 ITALY
16.1.7 SPAIN
16.1.8 NETHERLANDS
16.1.9 BELGIUM
16.1.10 SWITZERLAND
16.1.11 SWEDEN
16.1.12 NORWAY
16.1.13 DENMARK
16.1.14 FINLAND
16.1.15 REST OF EUROPE
17 EUROPE FMD VACCINE MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
19.1.1 COMPANY SNAPSHOT
19.1.2 COMPANY SHARE ANALYSIS
19.1.3 PRODUCT PORTFOLIO
19.1.4 RECENT DEVELOPMENT
19.2 CEVA SANTÉ ANIMALE
19.2.1 COMPANY SNAPSHOT
19.2.2 COMPANY SHARE ANALYSIS
19.2.3 PRODUCT PORTFOLIO
19.2.4 RECENT DEVELOPMENT
19.3 CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 INDIAN IMMUNOLOGICALS LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 BIOGÉNESIS BAGÓ
19.5.1 COMPANY SNAPSHOT
19.5.2 COMPANY SHARE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENT
19.6 BIOVET PRIVATE LTD
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENT
19.7 BRILLIANT BIO PHARMA
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 DOLLVET
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENT
19.9 ENIMMUNE CORP.
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENT
19.1 JINYU BIOTECHNOLOGY CO., LTD.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 KENYA VETERINARY VACCINES PRODUCTION INSTITUTE
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LIMOR DE COLOMBIA SAS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 MEVAC FOR VACCINES
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 NATIONAL VETERINARY INSTITUTE
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 SHCHELKOVO BIOCOMBINAT
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 SHANGHAI SHEN LIAN BIOMEDICAL CORPORATION
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 VETAL S.A.
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 VECOL
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
19.19 WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENT
19.2 ZOETIS SERVICES LLC
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
List of Table
TABLE 1 EUROPE FMD VACCINE PRICING STRUCTURE
TABLE 2 FMD SEROTYPE PREVALENCE BY REGION
TABLE 3 ECONOMIC IMPACT OF FMD OUTBREAKS
TABLE 4 MANUFACTURER POSITIONING MAP
TABLE 5 FMD INCIDENCE, MORBIDITY, AND EPIDEMIOLOGICAL RATES
TABLE 6 FMD SEROTYPE PREVALENCE BY REGION
TABLE 7 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE EUROPE FMD VACCINE MARKET
TABLE 8 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE EUROPE FMD VACCINE MARKET
TABLE 9 DISTRIBUTION OF PROJECTS BY SPECIES AND PHASE EUROPE FMD VACCINE MARKET
TABLE 10 EUROPE CLINICAL TRIAL MARKET FOR EUROPE FMD VACCINE MARKET
TABLE 11 DOSAGE FORM CHARACTERISTICS OF FMD VACCINES
TABLE 12 DOSAGE AVAILABILITY OF MARKETED FMD VACCINES
TABLE 13 THERAPEUTIC PORTFOLIO DIVERSIFICATION IN FMD VACCINES
TABLE 14 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2025
TABLE 15 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 16 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 17 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2025
TABLE 18 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 19 EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 21 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 22 EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 EUROPE MULTIVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 24 EUROPE MONOVALENT VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 25 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 26 EUROPE INTRAMUSCULAR IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 27 EUROPE SUBCUTANEOUS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 28 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 29 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 30 EUROPE BOVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 31 EUROPE PORCINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 EUROPE OVINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 33 EUROPE CAPRINE IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 36 EUROPE LIQUID VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 EUROPE LYOPHILIZED (FREEZE-DRIED) VACCINES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 EUROPE FMD VACCINE MARKET, BY APPLICATION, 2025
TABLE 40 EUROPE ROUTINE PROPHYLACTIC VACCINATION IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 EUROPE EMERGENCY VACCINATION (OUTBREAK CONTROL) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 43 EUROPE FMD VACCINE MARKET, BY END USER, 2025
TABLE 44 EUROPE COMMERCIAL LIVESTOCK FARMS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 EUROPE VETERINARY HOSPITALS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 46 EUROPE VETERINARY CARE CENTERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 EUROPE VACCINATION CENTRES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
TABLE 50 EUROPE DIRECT SALES (GOVERNMENT PROCUREMENT & TENDER SUPPLY) IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 51 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 52 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 EUROPE OTHERS IN FMD VACCINE MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 EUROPE FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 55 EUROPE FMD VACCINE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 56 EUROPE
TABLE 57 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 59 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 60 EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 61 EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 62 EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 64 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 65 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 EUROPE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 67 EUROPE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 68 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 69 EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 70 TURKEY
TABLE 71 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 72 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 73 TURKEY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 74 TURKEY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 75 TURKEY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 TURKEY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 77 TURKEY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 78 TURKEY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 79 TURKEY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 TURKEY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 81 TURKEY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 82 TURKEY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 83 TURKEY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 84 RUSSIA
TABLE 85 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 87 RUSSIA FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 88 RUSSIA CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 RUSSIA NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 90 RUSSIA FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 91 RUSSIA FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 92 RUSSIA FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 RUSSIA FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 RUSSIA FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 95 RUSSIA FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 96 RUSSIA FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 97 RUSSIA RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 98 GERMANY
TABLE 99 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 101 GERMANY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 102 GERMANY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 103 GERMANY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 GERMANY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 105 GERMANY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 106 GERMANY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 GERMANY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 GERMANY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 109 GERMANY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 110 GERMANY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 111 GERMANY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 112 FRANCE
TABLE 113 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 115 FRANCE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 116 FRANCE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 FRANCE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 118 FRANCE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 FRANCE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 120 FRANCE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 FRANCE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 FRANCE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 123 FRANCE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 124 FRANCE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 125 FRANCE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 126 U.K.
TABLE 127 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 129 U.K. FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 130 U.K. CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 131 U.K. NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 132 U.K. FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 133 U.K. FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 134 U.K. FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 U.K. FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 U.K. FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 137 U.K. FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 138 U.K. FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 139 U.K. RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 140 ITALY
TABLE 141 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 143 ITALY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 144 ITALY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 ITALY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 ITALY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 147 ITALY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 148 ITALY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 149 ITALY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 150 ITALY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 151 ITALY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 152 ITALY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 153 ITALY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 SPAIN
TABLE 155 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 157 SPAIN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 158 SPAIN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 159 SPAIN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 160 SPAIN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 161 SPAIN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 162 SPAIN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 SPAIN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 SPAIN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 165 SPAIN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 166 SPAIN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 167 SPAIN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 168 NETHERLANDS
TABLE 169 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 171 NETHERLANDS FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 172 NETHERLANDS CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 173 NETHERLANDS NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 NETHERLANDS FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 175 NETHERLANDS FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 176 NETHERLANDS FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 NETHERLANDS FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 178 NETHERLANDS FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 179 NETHERLANDS FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 180 NETHERLANDS FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 181 NETHERLANDS RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 182 BELGIUM
TABLE 183 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 184 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 185 BELGIUM FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 186 BELGIUM CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 187 BELGIUM NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 188 BELGIUM FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 189 BELGIUM FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 190 BELGIUM FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 BELGIUM FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 192 BELGIUM FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 193 BELGIUM FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 194 BELGIUM FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 195 BELGIUM RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 196 SWITZERLAND
TABLE 197 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 199 SWITZERLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 200 SWITZERLAND CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 SWITZERLAND NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 202 SWITZERLAND FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 203 SWITZERLAND FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 204 SWITZERLAND FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 SWITZERLAND FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 SWITZERLAND FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 207 SWITZERLAND FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 208 SWITZERLAND FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 209 SWITZERLAND RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 210 SWEDEN
TABLE 211 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 213 SWEDEN FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 214 SWEDEN CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 215 SWEDEN NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 SWEDEN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 217 SWEDEN FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 218 SWEDEN FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 219 SWEDEN FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 220 SWEDEN FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 221 SWEDEN FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 222 SWEDEN FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 223 SWEDEN RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 224 NORWAY
TABLE 225 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 227 NORWAY FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 228 NORWAY CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 229 NORWAY NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 230 NORWAY FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 231 NORWAY FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 232 NORWAY FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 NORWAY FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 234 NORWAY FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 235 NORWAY FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 236 NORWAY FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 237 NORWAY RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 238 DENMARK
TABLE 239 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 240 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 241 DENMARK FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 242 DENMARK CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 243 DENMARK NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 244 DENMARK FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 245 DENMARK FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 246 DENMARK FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 247 DENMARK FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 248 DENMARK FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 249 DENMARK FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 250 DENMARK FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 251 DENMARK RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 252 FINLAND
TABLE 253 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 254 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 255 FINLAND FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 256 FINLAND CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 257 FINLAND NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 FINLAND FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 259 FINLAND FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 260 FINLAND FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 261 FINLAND FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 262 FINLAND FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 263 FINLAND FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 264 FINLAND FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 265 FINLAND RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 266 REST OF EUROPE
TABLE 267 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (THOUSAND UNITS)
TABLE 269 REST OF EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2033 (USD PER UNIT)
TABLE 270 REST OF EUROPE CONVENTIONAL VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 271 REST OF EUROPE NEXT-GENERATION / ADVANCED VACCINES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 272 REST OF EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 273 REST OF EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2033 (USD THOUSAND)
TABLE 274 REST OF EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 275 REST OF EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 REST OF EUROPE FMD VACCINE MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)
TABLE 277 REST OF EUROPE FMD VACCINE MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 278 REST OF EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 279 REST OF EUROPE RETAIL SALES IN FMD VACCINE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 EUROPE FMD VACCINE MARKET: SEGMENTATION
FIGURE 2 EUROPE FMD VACCINE MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE FMD VACCINE MARKET: DROC ANALYSIS
FIGURE 4 EUROPE FMD VACCINE MARKET: EUROPE VS REGIONAL ANALYSIS
FIGURE 5 EUROPE FMD VACCINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE FMD VACCINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE FMD VACCINE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE FMD VACCINE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE FMD VACCINE MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 EUROPE FMD VACCINE MARKET: SEGMENTATION
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 RISING PREVALENCE OF FOOT-AND-MOUTH DISEASE AND INCREASING GOVERNMENT-LED MASS VACCINATION PROGRAMS EXPECTED TO DRIVE THE EUROPE FMD VACCINE MARKET IN THE FORECAST PERIOD OF 2026 TO 2033
FIGURE 14 CONVENTIONAL VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE FMD VACCINE MARKET IN 2026 & 2033
FIGURE 15 STANDARD DOSING SCHEDULE OF FMD VACCINE
FIGURE 16 TOP ENTITIES BASED ON R&D GLANCE FOR EUROPE FMD VACCINE MARKET
FIGURE 17 DROC ANALYSIS
FIGURE 18 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 19 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2025
FIGURE 20 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE, 2018-2032
FIGURE 21 EUROPE FMD VACCINE MARKET, BY VACCINE TYPE
FIGURE 22 EUROPE FMD VACCINE MARKET, BY TYPE, 2025
FIGURE 23 EUROPE FMD VACCINE MARKET, BY TYPE
FIGURE 24 EUROPE FMD VACCINE MARKET, BY TYPE, 2018-2032
FIGURE 25 EUROPE FMD VACCINE MARKET, BY TYPE
FIGURE 26 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2025
FIGURE 27 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 28 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE, 2018-2032
FIGURE 29 EUROPE FMD VACCINE MARKET, BY VACCINATION ROUTE
FIGURE 30 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2025
FIGURE 31 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 32 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE, 2018-2032
FIGURE 33 EUROPE FMD VACCINE MARKET, BY ANIMAL TYPE
FIGURE 34 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2025
FIGURE 35 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 36 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE, 2018-2032
FIGURE 37 EUROPE FMD VACCINE MARKET, BY FORMULATION TYPE
FIGURE 38 EUROPE FMD VACCINE MARKET, BY APPLICATION, 2025
FIGURE 39 EUROPE FMD VACCINE MARKET, BY APPLICATION
FIGURE 40 EUROPE FMD VACCINE MARKET, BY APPLICATION, 2018-2032
FIGURE 41 EUROPE FMD VACCINE MARKET, BY APPLICATION
FIGURE 42 EUROPE FMD VACCINE MARKET, BY END USER, 2025
FIGURE 43 EUROPE FMD VACCINE MARKET, BY END USER
FIGURE 44 EUROPE FMD VACCINE MARKET, BY END USER, 2018-2032
FIGURE 45 EUROPE FMD VACCINE MARKET, BY END USER
FIGURE 46 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 47 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 48 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 49 EUROPE FMD VACCINE MARKET, BY DISTRIBUTION CHANNEL
FIGURE 50 EUROPE FMD VACCINE MARKET SNAPSHOTS
FIGURE 51 EUROPE FMD VACCINE MARKET: COMPANY SHARE 2025 (%)
